← Every applicant
Maia Pharms Inc FDA Approvals
4 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| DAPTOMYCINNew drugNov 21, 2024POWDER, INTRAVENOUS |
| SINCALIDENew drugNov 22, 2022POWDER, INTRAVENOUS |
| BORTEZOMIBNew drugJul 27, 2022SOLUTION, INTRAVENOUS |
| SODIUM PHENYLACETATE AND SODIUM BENZOATENew drugJun 10, 2021SOLUTION, INTRAVENOUS |